Diabetic Retinopathy is the leading cause of blindness in the world. Previous studies have documented beneficial effects of physiologic administration of pulsatile insulin on a variety of diabetic complications such as nephropathy, hypertension, glycemic control, etc. Similar pathogenetic mechanisms have been postulated for diabetic retinal disease. This study examines the effect of pulsatile insulin on patients with varying stages of diabetic retinal disease.

I recently came across this website which claims: American Diabetes Therapy Centers are focused on the treatment of Chronic Diabetes. We provide weekly insulin therapy that is necessary to move the sickest of diabetics to a state of wellness. We are able to achieve this by our patented therapy called Cellular Activation Therapy.

The evidence does not support a conclusion that outpatient intravenous insulin therapy improves health outcomes in Medicare beneficiaries. Therefore, CMS has determined that outpatient intravenous insulin therapy is not reasonable and necessary for any indication under section 1862(a)(1)(A) of the Social Security Act. Services comprising an Outpatient Intravenous Insulin Therapy regimen are nationally noncovered under Medicare when furnished pursuant to an outpatient intravenous insulin therapy regimen.

Patients are often confused about the process of diabetic treatment, this FAQ helps alleviate that process and informs you of our process in Forth Worth

Life Pulse Health is committed to the vision of Revolutionizing the Delivery of Diabetes Healthcare